Collaborations between pioneering tech companies and pharma are transforming the healthcare landscape. Major tech companies, from Amazon through to Google have announced partnerships with pharmaceutical companies, promising new innovations that will change the landscape of pharma as we know it.
While these partnerships may be able to deliver many benefits, Dr Andrew Rut argues that the industry must proceed with caution. The speed of technological innovation means that regulation and monitoring can struggle to keep pace – risking patients’ data, genetic privacy and even the health of patients themselves.
In his recent article with PharmaTimes, Dr Andrew Rut outlines the landscape of tech innovation in the evolving pharmaceuticals industry, outlining the ever growing importance of data protection.
Read more here
